Ozempic Maker Novo Nordisk Faces Massive Lawsuits Over Causing Blindness – Investors Beware

In this Market Mondays clip, Rashad Bilal, Troy Millings, and Ian Dunlap dive deep into the multi-billion dollar lawsuits facing pharmaceutical giants Novo Nordisk and Eli Lilly over their blockbuster drug Ozempic and similar weight loss treatments. With over 2,000 federal lawsuits piling up—worth more than $2 billion—the team explores the risks and side effects, including rare vision problems, stomach paralysis, and severe kidney damage, now at the center of these legal battles.

Rashad shares his early warnings about the rapid rise of Ozempic and reflects on the cyclical history of “miracle” weight loss drugs that ultimately face safety concerns and legal troubles. Drawing a parallel from global affairs and the importance of studying history—whether in geopolitics or investing—the hosts break down why this pattern was predictable and how investors can learn from it.

Troy and Ian highlight the importance of understanding a company’s product portfolio, leadership, and resilience in the face of crisis, comparing Novo Nordisk to Eli Lilly and why Lilly may be better positioned to withstand industry fallout. The discussion also touches on cultural perspectives towards medicine, the impact of Western pharmaceutical practices, and the potential dangers of fast fixes for complex health issues like obesity and diabetes.

Whether you’re an investor, health enthusiast, or simply curious about the latest headlines in the pharmaceutical industry, this clip unpacks what’s really going on behind the lawsuits, the stakes for Novo Nordisk and Eli Lilly, and what smart investors should watch out for next.

*Timestamps available upon request.*

*Don’t forget to like, share, and subscribe to Market Mondays for more insightful breakdowns on current financial events!*

#Ozempic #NovoNordisk #EliLilly #MarketMondays #Pharmaceuticals #WeightLoss #Investing #StockMarket #Lawsuits #HealthNews

Our Sponsors:
* Check out PNC Bank: https://www.pnc.com
* Check out Square: https://square.com/go/eyl


Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy

See omnystudio.com/listener for privacy information.

Episode Transcript

Speaker 1 (00:01):
Earners. What's up.

Speaker 2 (00:02):
You ever walk into a small business and everything just
works like The checkout is fast, the receipts are digital,
tipping is a breeze, and you're out the door before
the line even builds. Odds are they're using Square. We
love supporting businesses that run on Square because it just
feels seamless. Whether it's a local coffee shop, a vendor
at a pop up market, or even one of our

(00:23):
merch partners, Square makes it easy for them to take payments,
manage inventory, and run their business with confidence, all from
one simple system. If you're a business owner or even
just thinking about launching something soon, Square is hands down
one of the best tools out there to help you start, run,
and grow. It's not just about payments, it's about giving

(00:45):
you time back so you can focus on what matters
most Ready. To see how Square can transform your business,
visit Square dot com backslash go backslash eyl to learn
more that Square dot com backslash, go backslash eyl. Don't wait,
don't hesitate. Let's Square handle the back end so you
can keep pushing your vision forward. This episode is brought

(01:10):
to you by P and C Bank, a lot of
people think podcasts about work are boring, and sure they
definitely can be, but understanding of professional's routine shows us
how they achieve their success little by little, day after day.
It's like banking with P and C Bank. It might
seem boring to save, plan and make calculated decisions with
your bank, but keeping your money boring is what helps

(01:33):
you live or more happily fulfilled life. P and C
Bank Brilliantly Boring since eighteen sixty five. Brilliantly Boring since
eighteen sixty five is a service mark of the PNC
Financial Service Group, Inc. P and C Bank National Association
Member FDIC.

Speaker 3 (01:51):
All right, Novo Nordic and Eli Lilly are both facing
a growing federal multi district litigation over two thousand lawsuits
so far, which are estimated to be, you know, valued
at over two billion dollars as far as like how
much they're actually asking for over in o Zimpic and

(02:16):
similar drugs. Some cases allege rare vision problems among other issues.
So okay, we'll talk about both companies, but let's talk
about Novo first. And you know, the Ozimpic conversation is
interested in it because I hate to say that I
told you so, but I did because last year I

(02:36):
was like, you know, as far as seen this movie
happen before, we don't know what's gonna happen next. But
whenever something good happens, there's a Chinese parable. And if
you watch the movie Charlie Wilson's War, right at the
end of the movie, they tell the parable because Charlie
Wilson's War is about Afghanistan history. Let's go into a

(02:59):
history rabbit hole. Okay, Afghanistan in the eighties was fighting
the Soviet Union. At the time, the Soviet Union was
America's biggest enemy, right, so what did America do? America
backed the rebels in Afghanistan and Afghanistan pulled off a

(03:24):
very unlikely defeat. Who was who was one of the
leaders of the rebels in Afghanistan that America funded? Put
in Chat put in Chat? This is like, uh, what's that.

Speaker 1 (03:40):
Show, dude, bake up the court.

Speaker 3 (03:45):
Who was one of the leaders, who was one of
the leaders in Afghanistan in their fight against the Soviet
Union that the United States of America funded?

Speaker 1 (03:58):
Riot boy?

Speaker 3 (03:59):
Oh sama?

Speaker 1 (04:01):
Then love? Is that in the YouTube privacy?

Speaker 3 (04:07):
No, that's the historical fact. That's that's not controversial, that's historical.
That's a document. That's a sixty minute special document Jesus.

Speaker 4 (04:18):
That might not be in the global that should be
in the global studies curriculum.

Speaker 1 (04:22):
I should know that. Okay.

Speaker 3 (04:24):
So at the end, so at the end, everybody's happy
that they won the war, right, And Charlie Wilson and
not the Charlie Wilson that we know. Charlie Wilson was
a senator, but he was telling he was lobbying the
Congress that look, we need to we need to support Afghanistan,

(04:49):
help them rebuild their country because if not, it's a
vacuum and it's going to go into chaos and they're
gonna end up hating us. Nobody took them, siou. They
never gave any money, They didn't rebuild the country. They
just left them alone and just say, yeah, you're on
your own now. The rise of the Talent Band comes
directly from that, say that, to say, you never know

(05:14):
in life. You gotta be patient. You gotta be patient.
What looks like a blessing could be a curse. What
looks like what looks like a curse can be a blessing.
When this whole ozimpic thing started to go crazy. I said, listen,
most good things have some level of negative side effect.

Speaker 1 (05:33):
Let's see what happens.

Speaker 3 (05:35):
I just had a strong suspicion that if people are
losing weight this quickly, there's a negative trade off, and
that negative trade off would lead to billions of dollars
in lawsuits down the line. Lo and behold. One year later,
that's exactly what happens. Stock went from one hundred and
forty two dollars to fifty four dollars currently, fell off

(05:59):
a cliff, going blind.

Speaker 5 (06:02):
That's crazywns. We've ever seen for a publicly traded company too.

Speaker 4 (06:07):
In that space inside the lawsuit, here are the side
effects that are actually going to be a part of litigation.
Stomach paralysis, intestinal blockages, persistent vomiting, go back issues, pancreatis,
kidney damage, and sunning.

Speaker 1 (06:22):
Vision loss linked to a condition called naion. The vision losses.
But that's crazy. Yeah, that's crazy vision.

Speaker 3 (06:31):
You're taking medicine to lose weight and then you just
can't see one day.

Speaker 1 (06:35):
Well, you're taking it for diabetes first.

Speaker 3 (06:37):
Well most people, they figured out people just started taking
it just to lose weight.

Speaker 1 (06:41):
Yeah.

Speaker 3 (06:42):
Now I'm very sensitive that obesity is an epidemic in
our nation, in our community. So I don't want to
be insensitive to anybody that has taken ozmpic. But nine
times out of ten, when you're doing things and you're
you're cutting corners, it's going to You're going to come back.

(07:05):
So their defense and I'm not here to defend them.

Speaker 4 (07:07):
Inside the litigation, Chan says, they're saying that, yes, all
drugs do come aside effects, but they're at there actively
suing pharmacies for producing unapproved versions of the g lp ones.
So people would get in the off brand is what
they're saying. Right, Like you weren't getting with GOVI got
cut twice. You can't get stepped on it.

Speaker 3 (07:30):
Got stepped on cut. You know what's so crazy too?
Like shout out to my guy Chocolate. He's a designer
from Ghana. So he came to America for investmentest and
I saw him the first day that he came and
he had a headache. He was with him and his
other guy and I'm like, yo, you need a m
and he.

Speaker 1 (07:49):
Was like.

Speaker 3 (07:51):
He's like we don't take He's like from Africa, Like
we're going to take a natural route. Then he gave
me a whole ten minute education on a natural room
and how you how you can cure headaches naturally?

Speaker 1 (08:04):
Dad.

Speaker 3 (08:04):
But the way he said avil, you would think I
offered him crack cocaine. But that goes back to our
Western We have so much medicine that we don't even
think about about it. We don't think about what's natural,
We don't think about how can we do this organically?
We just think, Yo, right, I'm just gonna go to

(08:25):
CVS and I'm gonna get right until until you until
you have these side effects. So be careful to anybody
that's taking these drugs because obviously it has a lot
of negative side effects. Now, as far as the business
is concerned, Nova was a stock that was flying high
and it's come down dramatically.

Speaker 1 (08:43):
Is it over?

Speaker 5 (08:46):
No, it's not over because I don't want to do
the dead or a live thing. Are they in critical condition?

Speaker 1 (08:52):
Yes?

Speaker 5 (08:53):
Like going back to best in class. At one point
I had people telling me Novo was a better company
than Lily. How also, too write this down, you have
to study the history of the category. Any company that
has a product that is publicly traded that is guaranteed
to have you lose weight. Going back to Finn Finn

(09:15):
of the nineteen eighties and nineteen nineties, this category normally
has been a.

Speaker 3 (09:22):
Disaster.

Speaker 5 (09:23):
Novo had Cockrisima back in the day. Like this entire
class of rapid result weight loss. The issue is always
heart or stomach issues or liver issues. So it may
have a blockbuster rise for a little bit, but it's
not sustainable.

Speaker 1 (09:38):
The things that makes Littally different.

Speaker 5 (09:39):
They have a bunch of other drugs, world class executive
leadership and different modes that Novo does not have. But
if you go to look at the history of these
going back to the nineteen going back to nineteen sixty four,
within seven years there's lawsuits or collapse in the stock
tie to weight law products. It's not natural like and

(10:03):
then even gop ones the venom from a.

Speaker 1 (10:07):
Geala lizard astracted.

Speaker 5 (10:11):
It's not probably so you're putting but that was for
my Christians. If you're putting lizard and snake venom in
your body to get the weight of the world off
of you, yeah, that makes I don't even want to
go into the inferias reptilian lord world view. But that's
not what I want to do. Knowing the source of

(10:32):
the thing is really important. So this space as a whole,
it's not one that I like to even look to
invest in long term.

Speaker 4 (10:41):
The snake thing is a little bit exaggerated, a little bit,
A little bit. I did the deep dive into that.
I was because I was interested. I'm like, like, oh,
this is crazy, but it's Novo dead. No, they're not dead.
Five years ago they were trading thirty dollars. Think about that.
I'm going to say, they make you get back to that.

Speaker 1 (11:02):
Now, can I land the plane? I land the plane.
They were at.

Speaker 4 (11:05):
Thirty dollars right before the weight loss craze happened, right
they o Zepik was the name. It also became like
band aid. And obviously Lily has come in the problem.
And I think you laid it out pretty nicely. The
one thing that they don't have is they're not an
American company.

Speaker 6 (11:21):
An illegal alien from Guatemala charged with raping a child
in Massachusetts. An MS thirteen gang member from Al Salvador
accused of murdering a Texas man of Venezuelan charged with
filming and selling child pornography in Michigan. These are just
some of the heinous migrant criminals caught because of President
Donald J. Trump's leadership. I'm Christy Noman, the United States

(11:45):
Secretary of Homeland Security. Under President Trump, attempted illegal border
crossings are at the lowest levels ever recorded, and over
one hundred thousand illegal aliens have been arrested. If you
were here illegally, your next you will be find nearly
one thousand dollars a day, imprisoned and deported. You will
never return. But if you register using our CBP home

(12:08):
app and leave now, you could be allowed to return legally.
Do what's right. Leave now. Under President Trump, America's laws,
border and families will be protected.

Speaker 1 (12:19):
Sponsored by the United States Department of Homeland Security.